Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Statement of Cash Flows [Abstract]
Net Cash Provided by (Used in) Financing Activities	$ 15,106	$ 18,618
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	(3,654,223)	2,736,748
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	(3,773,014)	23,605
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:
Depreciation and amortization	124,012	169,712
Stock-based compensation	190,331	446,077
AllowanceForDoubtfulAccountsCharge	49,361	0
IdleFacilityImpairmentCharge	400,000	0
Inventory Write-down	2,595,884	0
Changes in operating assets and liabilities:
Accounts receivable	734,629	1,319,871
Inventories	(897,734)	(719,303)
Increase (Decrease) In Collaboration Receivable	(189,008)	0
Prepaid expenses and other current and long-term assets	243,536	358,661
Accounts payable	(572,426)	572,153
Accrued expenses and compensation	(157,644)	(408,687)
Increase (Decrease) in Accrued Product Returns	(412,658)	(856,898)
Increase (Decrease) in Deferred Collaboration Income	(1,956,522)	1,956,522
Net Cash Provided by (Used in) Operating Activities	(3,621,253)	2,861,713
Cash flows for investing activities:
Purchases of fixed assets	(48,076)	(143,583)
Net Cash Provided by (Used in) Investing Activities	(48,076)	(143,583)
Proceeds from Issuance or Sale of Equity	15,106	18,618
Cash flows from financing activities:
Cash and cash equivalents, end of year	3,126,206	6,780,429
Supplemental disclosure of cash flow information:
Common stock issued to settle employee incentive compensation obligations	0	294,264
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$ 3,126,206	$ 6,780,429